Latent trajectory modelling of pulmonary artery pressure in systemic sclerosis: a retrospective cohort study

被引:1
作者
Kida, Takashi [1 ,2 ]
Matsuzaki, Keiichi [3 ]
Yokota, Isao [4 ]
Kawase, Nozomu [5 ]
Kadoya, Masatoshi [5 ]
Inoue, Hironori [2 ,6 ]
Kukida, Yuji [6 ]
Kaneshita, Shunya [2 ,7 ]
Inoue, Takuya [2 ,7 ]
Wada, Makoto [2 ]
Kohno, Masataka [2 ]
Fukuda, Wataru [5 ]
Kawahito, Yutaka [2 ]
Iwami, Taku [1 ]
机构
[1] Kyoto Univ, Sch Publ Hlth, Grad Sch Med, Dept Prevent Serv, Kyoto, Japan
[2] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Inflammat & Immunol, Kyoto, Japan
[3] Kyoto Univ, Agcy Hlth Safety & Environm, Kyoto, Japan
[4] Hokkaido Univ, Grad Sch Med, Dept Biostat, Sapporo, Japan
[5] Japanese Red Cross Kyoto Daiichi Hosp, Ctr Rheumat Dis, Kyoto, Japan
[6] Japanese Red Cross Kyoto Daini Hosp, Dept Rheumatol, Kyoto, Japan
[7] Fukuchiyama City Hosp, Dept Rheumatol, Fukuchiyama, Japan
关键词
Systemic Sclerosis; Cardiovascular Diseases; Epidemiology; Ultrasonography; SYSTOLIC PRESSURE; DISEASE; AUTOANTIBODIES; HYPERTENSION; INVOLVEMENT; PROGRESSION; PREDICTION; PHENOTYPES; MORTALITY; SURVIVAL;
D O I
10.1136/rmdopen-2022-002673
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectivesTo visualise the trajectories of pulmonary arterial pressure (PAP) in systemic sclerosis (SSc) and identify the clinical phenotypes for each trajectory, by applying latent trajectory modelling for PAP repeatedly estimated by echocardiography.MethodsThis was a multicentre, retrospective cohort study conducted at four referral hospitals in Kyoto, Japan. Patients with SSc who were treated at study sites between 2008 and 2021 and who had at least three echocardiographic measurements of systolic PAP (sPAP) were included. A group-based trajectory model was applied to the change in sPAP over time, and patients were classified into distinct subgroups that followed similar trajectories. Pulmonary hypertension (PH)-free survival was compared for each trajectory. Multinomial logistic regression analysis was performed for baseline clinical characteristics associated with trajectory assignment.ResultsA total of 236 patients with 1097 sPAP measurements were included. We identified five trajectories: rapid progression (n=9, 3.8%), early elevation (n=30, 12.7%), middle elevation (n=54, 22.9%), late elevation (n=24, 10.2%) and low stable (n=119, 50.4%). The trajectories, in the listed order, showed progressively earlier elevation of sPAP and shorter PH-free survival. In the multinomial logistic regression analysis with the low stable as a reference, cardiac involvement was associated with rapid progression, diffuse cutaneous SSc was associated with early elevation and anti-centromere antibody was associated with middle elevation; older age of onset was associated with all three of these trajectories.ConclusionThe pattern of changes in PAP over time in SSc can be classified into five trajectories with distinctly different clinical characteristics and outcomes.
引用
收藏
页数:7
相关论文
共 27 条
[21]   Haemodynamic definitions and updated clinical classification of pulmonary hypertension [J].
Simonneau, Gerald ;
Montani, David ;
Celermajer, David S. ;
Denton, Christopher P. ;
Gatzoulis, Michael A. ;
Krowka, Michael ;
Williams, Paul G. ;
Souza, Rogerio .
EUROPEAN RESPIRATORY JOURNAL, 2019, 53 (01)
[22]   Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis [J].
Sobanski, Vincent ;
Giovannelli, Jonathan ;
Allanore, Yannick ;
Riemekasten, Gabriela ;
Airo, Paolo ;
Vettori, Serena ;
Cozzi, Franco ;
Distler, Oliver ;
Matucci-Cerinic, Marco ;
Denton, Christopher ;
Launay, David ;
Hachulla, Eric ;
Cerinic, Marco Matucci ;
Guiducci, Serena ;
Walker, Ulrich ;
Kyburz, Diego ;
Lapadula, Giovanni ;
Iannone, Florenzo ;
Distler, Oliver ;
Maurer, Britta ;
Jordan, Suzana ;
Becvar, Radim ;
Sierakowsky, Stanislaw ;
Bielecka, Otylia Kowal ;
Cutolo, Maurizio ;
Sulli, Alberto ;
Valentini, Gabriele ;
Cuomo, Giovanna ;
Vettori, Serena ;
Siegert, Elise ;
Rednic, Simona ;
Nicoara, Ileana ;
Kahan, Andre ;
Allanore, Yannick ;
Vlachoyiannopoulos, Panayiotis ;
Montecucco, Carlo ;
Caporali, Roberto ;
Stork, Jiri ;
Inanc, Murat ;
Carreira, Patricia E. ;
Novak, Srdan ;
Czirjak, Laszlo ;
Varju, Cecilia ;
Chizzolini, Carlo ;
Kucharz, Eugene J. ;
Kotulska, Anna ;
Kopec-Medrek, Magdalena ;
Widuchowska, Malgorzata ;
Cozzi, Franco ;
Rozman, Blaz .
ARTHRITIS & RHEUMATOLOGY, 2019, 71 (09) :1553-1570
[23]   Autoantibodies in systemic sclerosis [J].
Steen, VD .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2005, 35 (01) :35-42
[24]   Left Ventricular Diastolic Dysfunction Predicts Mortality in Patients With Systemic Sclerosis [J].
Tennoe, Anders H. ;
Murbraech, Klaus ;
Andreassen, Johanna C. ;
Fretheim, Havard ;
Garen, Torhild ;
Gude, Einar ;
Andreassen, Ame ;
Aakhus, Svend ;
Molberg, Oyvind ;
Hoffmann-Vold, Anna-Maria .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (15) :1804-1813
[25]  
van den Hoogen F, 2013, ANN RHEUM DIS, V72, P1747, DOI [10.1136/annrheumdis-2013-204424, 10.1002/art.38098]
[26]   New risk model is able to identify patients with a low risk of progression in systemic sclerosis [J].
van Leeuwen, Nina Marijn ;
Maurits, Marc ;
Liem, Sophie ;
Ciaffi, Jacopo ;
Marsan, Nina Ajmone ;
Ninaber, Maarten ;
Allaart, Cornelia ;
van Dongen, Henrike Gillet ;
Goekoop, Robbert ;
Huizinga, Tom ;
Knevel, Rachel ;
De Vries-Bouwstra, Jeska .
RMD OPEN, 2021, 7 (02)
[27]   Screening for pulmonary arterial hypertension in systemic sclerosis [J].
Weatherald, Jason ;
Montani, David ;
Jevnikar, Mitja ;
Jais, Xavier ;
Savale, Laurent ;
Humbert, Marc .
EUROPEAN RESPIRATORY REVIEW, 2019, 28 (153)